Drug Insights

Unlock the Power of Synapse: A Guide to Searching Dexamethasone

9 February 2024
2 min read

Dexamethasone, a small molecule drug molecule with a glucocorticoid receptor (GR) agonist action, has got all the science enthusiasts' tongues wagging. The GR, which is widely distributed across various cell types, is responsible for myriad physiological responses, including immune and inflammatory responses. This small molecule drug, Dexamethasone, binds to the GR, which sends shockwaves of change through gene expression and protein synthesis, consequently giving inflammation and immune system activity a taste of their own medicine.When it comes to treating various conditions, Dexamethasone takes the crown. This potent drug has proved its mettle in treating an impressive range of conditions, including but not limited to actinic cheilitis, light chain (AL) amyloidosis, ocular inflammation, macular edema, and anaphylaxis. Back in the day, on October 30, 1958, the FDA gave the nod to Dexamethasone. It was a time when Merck & Co., Inc., a pharmaceutical company that hailed from the United States, hit the bull's eye with this innovative drug that promised a bright future. Click on the image below to begin the exploration journey of Furosemide through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Sandoz Launches Tyruko®, a Unique Biosimilar for Multiple Sclerosis Treatment, in Germany
Latest Hotspot
3 min read
Sandoz Launches Tyruko®, a Unique Biosimilar for Multiple Sclerosis Treatment, in Germany
9 February 2024
Sandoz introduces Tyruko® (natalizumab), a first-of-its-kind biosimilar aimed at treating multiple sclerosis, now available in Germany.
Read →
How to Effectively Search for Furosemide on Synapse
Drug Insights
2 min read
How to Effectively Search for Furosemide on Synapse
9 February 2024
Furosemide is a small molecule NKCC2 inhibitor drug, blocking the sodium-potassium-chloride co-transporter in the kidney's ascending loop of Henle.
Read →
J&J Seeks FDA Approval for DARZALEX FASPRO in Treating Newly Diagnosed Multiple Myeloma Cases
Latest Hotspot
4 min read
J&J Seeks FDA Approval for DARZALEX FASPRO in Treating Newly Diagnosed Multiple Myeloma Cases
9 February 2024
Johnson & Johnson has filed an additional request with the FDA for authorization of its DARZALEX FASPRO formula as a therapy option for newly identified multiple myeloma cases eligible for transplant.
Read →
Your Ultimate Guide to Finding Clonazepam on Synapse
Drug Insights
2 min read
Your Ultimate Guide to Finding Clonazepam on Synapse
9 February 2024
KLONOPIN (clonazepam) is a benzodiazepine medication that was first approved by the FDA in 1975 for the treatment of seizure disorders and panic disorder.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.